Is Korea Prepared for an Alzheimer’s Disease-Modifying Therapy? Assessing the Korean Healthcare System Infrastructure and the Effect of Blood-Based Biomarker Tests

BACKGROUND: With the rapid demographic change in Korea, Alzheimer’s disease has become a primary concern. Recent developments in disease-modifying therapies provide hope that therapy may become available soon. The high disease prevalence and complex evaluation process will create challenges for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jun, Hankyung, Cho, Sang Kyu, Yoong, Joanne, Mattke, Soeren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Geriatrics Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024173/
https://www.ncbi.nlm.nih.gov/pubmed/33550774
http://dx.doi.org/10.4235/agmr.20.0082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024173/
https://www.ncbi.nlm.nih.gov/pubmed/33550774
http://dx.doi.org/10.4235/agmr.20.0082

Ejemplares similares